DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20213683

Role of methylergometrine versus oxytocin in the active management of third stage of labour: a randomised control trial

Sabitha Umapathy Srinivasan, Swarnamukhi P.

Abstract


Background: Postpartum haemorrhage (PPH) is the leading cause of maternal death globally. The routine practice of active management of third stage of labour has been shown to reduce haemorrhage by up to 60%. The present study evaluated the role of methylergometrine versus oxytocin in active management of third stage of labour in reducing the risk of PPH.

Methods: This study was conducted on a total of 400 women admitted in the labour ward of PESIMSR hospital, by using simple randomized design. The first study group included women who received intramuscular oxytocin (n=200) and, the second group included women who received intravenous Methylergometrine (n=200) within, one minute of delivery of the baby.

Results: The mean blood loss among study first and the second study group were 172.8 ml and 148.9 ml respectively (p<0.05) and, the mean duration of third stage of labour were 5.9 and 5.1 minutes respectively (p<0.05). The mean pre-and post-delivery haemoglobin values among the first and second group were 11.76 mg/dl, 10.46 mg/dl and, 11.76 mg/dl, 10.6 mg/dl respectively (p<0.05). There was an increase in the blood pressure in the ergometrine group and, slight decrease of blood pressure in oxytocin group.

Conclusions: The use of methyl ergometrine as part of active management of third stage of labour was associated with a significant reduction in mean blood loss value, duration of third stage of labour, and the additional need of oxytocic though, methylergometrine has significant side effects like nausea, vomiting and rise in blood pressure.


Keywords


Haemorrhage, Labour, Methylergometrine, Oxytocin

Full Text:

PDF

References


Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA. 2021. Available at: Apps.who.int.http://apps.who.int/iris/bitstream/handle/10665/68382/a81531.pdf;jsessionid=5F586C3DFF49F5F4B06645377120C536?sequence=1. Accessed 13 September, 2021.

WHO. Global estimates of maternal mortality for1995: Results of an in-depth review analysis and estimation strategy. Geneva: WHO. 2001. Available at: http://apps.who.int/iris/bitstream/handle/ 10665/66837/WHO_RHR_01.9.pdf?sequence=1. Accessed 13 September, 2021.

Dildy G. Postpartum Hemorrhage: New Management Options. Clin Obstet Gynecol. 2002;45(2):330-44.

Naz H, Sarwar I, Fawad A, Nisa AU. Maternal morbidity and mortality due to primary PPH--experience at Ayub Teaching Hospital Abbottabad. J Ayub Med Coll Abbottabad. 2008;20(2):59-65.

Adhikari S, Rana A, Bista KD. Active management of third stage of labour: comparison between prophylactic intramuscular methylergometrine and intramuscular oxytocin. NJ Obstet Gynaecol. 2008;2(2):24-8.

Mfinanga G, Kimaro G, Ngadaya E. Health facility-based Active Management of the Third Stage of Labor: findings from a national survey in Tanzania. Health Res Policy Syst. 2009;7:1.

Nair NV. Making motherhood safe. Health Action. 2001.

McDonald S, Prendiville W, Elbourne D. Prophylactic syntometrine versus oxytocin for delivery of the placenta. Cochrane Database Syst Rev. 2000;(2):CD000201.

Suman De K, Saha D, Koley AK, Saha A. Comparative Study of Ergometrine with Oxytocin in Controlling Third Stage Blood Loss-A Randomized Control Trial. Sch J App Med Sci. 2013;1(5):595-9.

Boopathi A, Nayak S, Rao A, Rao B. Oxytocin versus Methylergometrine in the Active Management of Third Stage of Labour. Open J Obstetr Gynecol. 2014;4:666-71.

Rajendran D, Shivanagappa M, Siddesh A, Gowda S. Oxytocin versus methyl ergometrine in the management of third stage of labor: a comparative study from a South Indian tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2016:1327-30.

Ramya KS, Shivanna S, Gopal N. Intravenous methergine versus intramuscular oxytocin in active management of third stage labour. Int J Recent Trends Sci Technol. 2015;12(2):260-4.